Cardiac transplantation in transthyretin amyloid cardiomyopathy: Outcomes from three decades of tertiary center experience

AIMS: Transthyretin cardiac amyloidosis (ATTR-CM) is a progressive and fatal cardiomyopathy. Treatment options in patients with advanced ATTR-CM are limited to cardiac transplantation (CT). Despite case series demonstrating comparable outcomes with CT between patients with ATTR-CM and non-amyloid ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Razvi, Yousuf, Porcari, Aldostefano, Di Nora, Concetta, Patel, Rishi K., Ioannou, Adam, Rauf, Muhammad U., Masi, Ambra, Law, Steven, Chacko, Liza, Rezk, Tamer, Ravichandran, Sriram, Gilbertson, Janet, Rowczenio, Dorota, Blakeney, Iona J., Kaza, Nandita, Hutt, David F., Lachmann, Helen, Wechalekar, Ashutosh, Moody, William, Lim, Sern, Chue, Colin, Whelan, Carol, Venneri, Lucia, Martinez-Naharro, Ana, Merlo, Marco, Sinagra, Gianfranco, Livi, Ugolino, Hawkins, Philip, Fontana, Marianna, Gillmore, Julian D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894650/
https://www.ncbi.nlm.nih.gov/pubmed/36741843
http://dx.doi.org/10.3389/fcvm.2022.1075806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894650/
https://www.ncbi.nlm.nih.gov/pubmed/36741843
http://dx.doi.org/10.3389/fcvm.2022.1075806

Ejemplares similares